mRNA Manufacturing and Single‐use Technology – A Perfect Liaison.

The Covid‐19 pandemic imposed a lockdown on the world. In this situation, the pharmaceutical industry reacted with incredible speed and delivered vaccines at the global scale in record time. Critical to this major accomplishment were existing mRNA vaccine expertise and single‐use manufacturing technologies. The combination of a moderate facility footprint requirement for mRNA production and the flexibility of disposable technology allowed rapid scale‐up and scale‐out of vaccine manufacturing, even over multiple continents. The present paper discusses opportunities provided by single‐use process solutions for mRNA manufacturing using the Covid‐19 vaccines as a case study. [ABSTRACT FROM AUTHOR]